What does the future hold for the California Institute for Regenerative Medicine (CIRM), also known as the California Stem Cell Agency? While new CIRM grants should be awarded up until 2017, CIRM is rightly thinking about its future. Californians should be paying attention and thinking ahead too. You might say that since I’m a CIRM […]
The Case for CIRM 2.0: Continuing California’s Stem Cell Leadership Read More »
Congratulations to Dr. Elena Cattaneo, the winner of the 2013 Stem Cell Person of the Year Award. Her lab studies neural stem cells, particularly as they relate to developing new therapies for Huntington’s Disease. Cattaneo is Director and Co-Founder of the Unistem, the Centre for Stem Cell Research at the University of Milano, Italy. She
Stem Cell Person of the Year 2013: Elena Cattaneo Read More »
You can jailbreak your iPhone, but perhaps you can jailbreak a cell too to turn it into a stem cell. In his very cool talk up here at the Till & McCulloch Meeting on Stem Cells yesterday, Andras Nagy characterized the reprogramming process to make iPS cells as “jailbreaking” cell fate. Nagy described some intriguing studies done on
Jailbreak Cell Fate to Reprogram Stem Cells Read More »
If there was one stem cell meeting I would absolutely not want to miss next month in November if at all possible, it is the 2013 World Alliance Forum “Future of Stem Cells” in San Francisco. Are you going? Win free tickets to this meeting here! Unfortunately I have a conflict so I will this
World Alliance Forum “Future of Stem Cells” features Shinya Yamanaka Read More »
In late 2010, Nicholas Wade, then a frequent science writer for the New York Times, wrote a frankly nasty piece on the stem cell field that was insulting and oversimplistic. Now today we have yet another piece in the NYT by Wade on stem cells, and he mostly makes a mess of it again, with
Nicholas Wade of the New York Times again Misses the Stem Cell Boat Read More »
By Paul Knoepfler Lakshmi Bharadwaj contributed to this article. See updated stem cell journal list for 2018 here. Important update on April 22, 2016. There are an increasing number of predatory journals out there and some use “stem cells” as a hook. This list is not an endorsement of these journals and in fact on
The Definitive Stem Cell Journal List Read More »
The Australian stem cell biotech Mesoblast (MSB) has reportedly reached a deal with the American stem cell biotech Osiris (OSIR) to buy Osiris’ mesenchymal stem cell (MSC) unit. This is a big development in the MSC field. Osiris and Mesoblast are two major players in this particular subfield of the stem cell world so this deal,
Mesoblast (MSB) buys Osiris (OSIR) stem cell unit Read More »
I’m really looking forward to this Saturday’s Berkeley Stem Cell Meeting. You should go! Tickets are just $5 and the lineup is great. This looks to be one of the best stem cell meetings in Northern California this year. Below is my interview with the organizers giving some background and perspectives on the meeting. 1.
Interview With Organizers of Tomorrow’s Berkeley Stem Cell Meeting Read More »
Nominations for Stem Cell Person of the Year 2013 closed last night and I ended up with a remarkable list of 30 nominees. I have included a few sentences about each one below, often taking verbiage directly from the nominator. The online voting on these nominees will start soon. The top vote getters will move
BioTime (BTX), via its subsidiary Asterias, has formally purchased the Geron (GERN) embryonic stem cell (ESC) research program and assets. Incidentally, Asterias in nature refers to a genus of sea stars including starfish and you can see it in their logo. Perhaps this was chosen given the amazing regenerative capacity of starfish? You may recall
Great news: BioTime Subsidiary Asterias Acquires Geron Embryonic Stem Cell Program Read More »